Management Team

Christopher A. Kroeger, M.D.
President and Chief Executive Officer
Read More


John Reardon, Ph.D.
Chief Scientific Officer
Read More


Doug Cowart, Pharm. D., FABCP, RAC
Executive Vice President-Development and Regulatory Affairs
Read More


Vince Kalish, Ph.D.
Senior Vice President, Chemistry & Pre-clinical Development
Read More


Frank Smart, M.D.
Medical Advisor
Read More



Nitroxyl Technology

Cardioxyl has developed proprietary expertise in the biology, physiology and chemistry of nitroxyl donors

View More

Our Mission

Cardioxyl's mission is to realize the potential of nitroxyl technology through the development of novel therapies that improve the health and quality of life of patients with serious cardiovascular disease.